Custom Content

Research suggests a new way to prevent MS

A vaccine used to prevent tuberculosis might also help people at high risk of developing multiple sclerosis, a new study suggests. Multiple sclerosis (MS) occurs when the immune system attacks the sheath that surrounds the body's nerve cells. Some people first are diagnosed with "clinically isolated syndrome." Symptoms include numbing and problems with vision, hearing and balance. About half of those with this syndrome will develop MS within 2 years. The new study…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In